ViaCyte tries again with potential diabetes cure – The San Diego Union-Tribune

The San Diego Union-TribuneAfter receiving an additional $20 million funding, San Diego’s ViaCyte is testing a new version of its stem cell-based diabetes therapy. With the funding from California’s stem cell agency, or CIRM, ViaCyte plans to get strong evidence within about 18 … …read more Source:: San Diego News By Google News

from WordPress http://ift.tt/2yB3Bh8
via IFTTT